Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
将FDA批准的药物重新定位为潜在的克氏锥虫克氏蛋白酶抑制剂：虚拟筛选、体外和体内研究
期刊:Molecules
影响因子:4.6
doi:10.3390/molecules22061015
Palos, Isidro; Lara-Ramirez, Edgar E; Lopez-Cedillo, Julio Cesar; Garcia-Perez, Carlos; Kashif, Muhammad; Bocanegra-Garcia, Virgilio; Nogueda-Torres, Benjamin; Rivera, Gildardo
